Hormones are chemical messengers secreted by endocrine glands directly into the bloodstream. However, despite traveling throughout the entire body, a given hormone only affects specific target cells. This selective response occurs because target cells possess specialized protein structures called hormone receptors. When a hormone binds to its specific receptor, it triggers a cascade of intracellular events known as signal transduction. This process alters cellular activity, metabolism, or gene expression, allowing the body to maintain homeostasis.
Hormones are broadly divided into two chemical classes, which dictate where their respective receptors are located and how they function:
Because water-soluble hormones cannot enter the cell, they act as first messengers. Binding to a cell-surface receptor activates an internal signaling cascade via second messengers like cyclic AMP (cAMP) or calcium ions. This intracellular amplification system rapidly alters existing cellular enzymes and proteins without needing to change gene transcription immediately. Common types include G protein-coupled receptors and enzyme-linked receptors.
Lipid-soluble hormones pass directly through the plasma membrane and bind to intracellular receptors located in the cytoplasm or the nucleus. The hormone-receptor complex then acts as a transcription factor, binding directly to specific regions of DNA. This process either stimulates or inhibits the transcription of target genes, leading to the synthesis of new proteins that carry out the hormone's long-term physiological effects.
Target cells can change their sensitivity to hormones by altering the number of receptors they display:
Hormone-related diseases are not always caused by abnormal hormone production; receptor failure is a frequent culprit. In type 2 diabetes mellitus, for instance, the pancreas often produces adequate insulin, but peripheral tissue receptors fail to respond properly—a condition known as insulin resistance. Similarly, genetic mutations can create non-functional receptors, rendering target tissues completely unresponsive despite normal or elevated hormone levels in the blood.